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Abstract
Mutations in the l(3)mbt tumour suppressor result in overproliferation of Drosophila larval brains. Recently, the derepression
of different gene classes in l(3)mbt mutants was shown to be causal for transformation. However, the molecular
mechanisms of dL(3)mbt-mediated gene repression are not understood. Here, we identify LINT, the major dL(3)mbt
complex of Drosophila. LINT has three core subunits—dL(3)mbt, dCoREST, and dLint-1—and is expressed in cell lines,
embryos, and larval brain. Using genome-wide ChIP–Seq analysis, we show that dLint-1 binds close to the TSS of tumour-
relevant target genes. Depletion of the LINT core subunits results in derepression of these genes. By contrast, histone
deacetylase, histone methylase, and histone demethylase activities are not required to maintain repression. Our results
support a direct role of LINT in the repression of brain tumour-relevant target genes by restricting promoter access.
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Introduction
Regulation of chromatin structure by enzymatic and non-
enzymatic mechanisms plays a pivotal role in the proliferation,
differentiation and transformation of cells. Components of histone
modifying protein complexes and ATP-dependent chromatin
remodelers are misexpressed or mutated in cancer and other
diseases [1]. While a connection between defective chromatin
regulation and disease is well established in numerous cases, the
nature and mechanisms of action of the protein complexes
involved are not well understood.
A temperature sensitive mutation in the Drosophila gene l(3)mbt
results in aberrant overproliferation of cells in the brains of third
instar larvae [2]. This generates malignant brain tumours with the
potential to metastasize. Two recent studies have identified genes
that are misexpressed in l(3)mbt
ts brain tumours [3,4]. l(3)mbt
inactivation results in the specific deregulation of 102 genes that
constitute the malignant brain tumour signature (MBTS) [3]. 32
MBTS genes encode proteins important for germ line function
and mutation of some of these genes rescues the l(3)mbt
ts
phenotype [3]. It was also reported that a group of 7 genes that
are targeted by the Salvador-Warts-Hippo (SWH) signaling
pathway are derepressed in brain tumour tissue and forced
overexpression of some of these genes replicates the l(3)mbt
ts
phenotype [4]. dL(3)mbt protein binds many of the MBTS
germline and SWH target genes suggesting that these genes are
direct targets of dL(3)mbt [4].
L3MBTL1 is the closest human homolog of dL(3)mbt. The
MBT domains of L3MBTL1 compact nucleosomes bearing
H4K20me1 or H1bK26me1 modifications in vitro [5]. L3MBTL1
chromatin association and L3MBTL1-mediated repression de-
pend to a large degree on H4K20 methylation and the H4K20-
specific histone methylase PR-SET7 [6]. L3MBTL1 is part of a
complex containing pRb, HP1c, H1b and core histones which has
been suggested to repress transcription by increasing nucleosome
compaction at target genes [5]. The individual contributions of
L3MBTL1 complex subunits to repression are not clear.
Drosophila L(3)mbt associates with the MybMuvB/dREAM
complex at substoichiometric levels [7]. Similar to the L3MBTL1
complex, MybMuvB/dREAM contains pRb proteins but lacks
HP1 and histone proteins [7,8]. Mutations in core components of
the MybMuvB/dREAM complex do not give rise to larval brain
tumours raising the possibility that repression of tumour-relevant
genes is maintained by a different dL(3)mbt complex.
Here, we use immunoaffinity and conventional chromatogra-
phy to purify LINT, the major dL(3)mbt complex in Drosophila.
LINT is composed of three subunits: dL(3)mbt, dCoREST and the
uncharacterised protein dLint-1. LINT is expressed in cell lines,
embryos and larval brains. Indirect immunofluorescence analysis
of larval polytene chromosomes revealed LINT subunit colocalisa-
tion at many interbands. In agreement with this finding, genome-
wide ChIP-Seq demonstrated that dL(3)mbt and dLint-1 bind
together in the vicinity of the transcriptional start site (TSS) of
many genes. RNAi-mediated depletion of LINT derepresses
MBTS germline genes in both cell lines and in larvae. By
contrast, SWH target genes are not derepressed in LINT depleted
cells. Repression of MBTS germline genes depends on the
presence of all three core LINT subunits at the promoter but is
not affected by depletion of dLsd1, dRpd3, dPR-Set7 and other
histone modifying enzymes suggesting that LINT represses
PLoS Genetics | www.plosgenetics.org 1 May 2012 | Volume 8 | Issue 5 | e1002676germline-specific genes by binding to their promoters and by
restricting access of transcription factors and RNA polymerase II.
Our study identifies the novel LINT complex as an important
repressor of germline-specific genes that are derepressed in
malignant brain tumours in Drosophila.
Results
dLint-1 is a novel dL(3)mbt-interacting protein
We fractionated nuclear extracts of Kc cells by gel filtration to
assess whether dL(3)mbt is a part of protein complexes. dL(3)mbt
eluted in fractions with an apparent molecular weight of 0.67–
2.0 MDa (Figure 1A). The bulk of dL(3)mbt separated from the
dREAM subunit RBF2 suggesting that dL(3)mbt exists in high
molecular weight complexes that are distinct from dREAM.
We established a S2 cell line stably expressing FLAG-tagged
dL(3)mbt to facilitate the identification of interacting proteins
(Figure S1A). Next, nuclear extracts were bound to FLAG
immunoaffinity resin, eluted with FLAG peptide and analyzed
by SDS-PAGE (Figure 1B). As a control, nuclear extract from cells
not expressing FLAG-tagged dL(3)mbt were processed in parallel.
Many polypeptides that were present in both purifications were
visualized by silver staining (Figure 1B, compare lanes 3 and 4).
Therefore, we consider the majority of these polypeptides to be
contaminants. However, two polypeptides of 185 kDa and
85 kDa, respectively, were specifically purified from FLAG-
dL(3)mbt expressing cells. The 185 kDa polypeptide was identified
by peptide mass fingerprinting as dL(3)mbt (Figure S1B). The
85 kDa polypeptide was identified as the gene product of CG1908,
a protein of unknown function. From hereon, we will refer to this
protein as dLint-1 (Drosophila L(3)mbt interacting protein 1).
Sequence analysis identified a cysteine-rich region near the C-
terminus of dLint-1 with similarities to a PHD finger (Figure S2).
We carried out in vitro interaction assays to verify that
recombinant dL(3)mbt and dLint-1 interact in a robust manner
(Figure 1C and 1D). FLAG-tagged dL(3)mbt bound specifically to
in vitro translated dLint-1 (Figure 1C). Furthermore, both proteins
coimmunoprecipitated from extracts of Sf9 cells infected with
recombinant baculoviruses (Figure 1D).
Next, we established an S2 line stably expressing FLAG-tagged
dLint-1 and used FLAG immunoaffinity purification to identify
dLint-1 interaction partners (Figure S1C). Several polypeptides
copurified with dLint-1 (Figure 1E). Peptide fingerprinting
identified these as dL(3)mbt, the histone demethylase dLsd1, the
corepressor dCoREST and the histone deacetylase dRpd3 (Figure
S1D). The identity of these proteins was verified by Western blot
(Figure 1F). Three alternative splice forms of dCoREST exist, two
of which - a 95 kDa and a 130 kDa polypeptide - are recognized
by the antibody we have used [9]. Comparison of signal intensities
between isoforms revealed that dLint-1 associated predominantly
with the 95 kDa polypeptide.
We raised two dLint-1-specific antisera to characterize the
endogenous dLint-1 protein. Both antisera recognized an 80 kDa
polypeptide in a Western blot analysis of Kc nuclear extract
(Figure 2A). Treatment of Kc cells with double stranded RNA
directed against the dLint-1 mRNA greatly decreased the intensity
of these bands demonstrating that both antisera are specific for
dLint-1. We used dLint-1 antiserum to immunoprecipitate nuclear
extracts. Coprecipitation of dL(3)mbt, dLsd1, the 95 kDa isoform
of dCoREST and dRpd3 confirmed that these proteins interacted
with endogenous dLint-1 in nuclear extracts derived from both cell
lines and embryos (Figure 2B, Figure S3).
Identification of the LINT complex
Endogenous dLint-1 and the 95 kDa dCoREST isoform
coeluted with dL(3)mbt in high molecular weight gel filtration
fractions (Figure 2C, fractions 15–21). dLsd1 and dRpd3 were
detectable in the same fractions. However, unlike dL(3)mbt, dLint-
1 and dCoREST, these proteins did not peak in fraction 17.
Strong dLint-1, dLsd1, dCoREST and dRpd3 signals were
apparent in fractions 23 to 31 (670 kDa to 160 kDa). However,
we failed to detect dL(3)mbt in these fractions. The Superose 6
elution profiles are consistent with the presence of dL(3)mbt,
dLint-1 and dCoREST in a high molecular weight complex. In
addition, one or more additional dLint-1 containing complexes
with smaller apparent molecular weight appear to exist.
We used ion exchange chromatography to separate different
dLint-1-containing complexes (Figure 2D). Sequential fraction-
ation of nuclear extract over Q-Sepharose and MonoQ columns
separated two pools of dLint-1 eluting in different MonoQ
fractions. dLint-1 coeluted with dLsd1 and dCoREST in fractions
22 to 24. These fractions did not contain detectable levels of
dL(3)mbt. A second pool of dLint-1 coeluted with dL(3)mbt and
dCoREST in fraction 32. This fraction did not contain significant
amounts of dLsd1.
The elution profiles from both gel filtration and ion exchange
columns suggest that dCoREST and dLsd1 polypeptides likely
occur in multiple protein complexes. dLint-1, however, appears to
be restricted to two separate complexes, one containing dCoREST
and dLsd1, the other containing dCoREST and dL(3)mbt. In
contrast, dL(3)mbt appears to exist exclusively in a single complex
together with dLint-1 and dCoREST. We focused our analysis on
the dL(3)mbt/dLint-1/dCoREST complex which we will refer to
from hereon as the LINT (dL(3)mbt interacting protein) complex.
dL(3)mbt mutant larvae develop brain tumours at the third
instar stage. To determine if LINT is present in this tissue we
prepared extracts from larval brains. Immunoprecipitation with
dLint-1 antibody resulted in the coprecipitation of dL(3)mbt and
dCoREST (Figure 2E). Although dLsd1 and dRpd3 were present
in these extracts they failed to coprecipitate. We conclude that
third instar larval brains contain the LINT complex. Whether
other dLint-1 containing complexes exist in this tissue is unclear.
dL(3)mbt and dLint-1 colocalise on polytene
chromosomes
We next asked if subunits of LINT bind chromatin and
colocalise at the same regions. Our dL(3)mbt antibody failed to
detect endogenous dL(3)mbt when we analyzed polytene chromo-
somes by indirect immunofluorescence (data not shown). However,
overexpression of dL(3)mbt in transgenic larvae allowed the
detection of numerous interbands occupied by recombinant
Author Summary
Mutations in the l(3)mbt result in the formation of brain
tumours. The molecular basis underlying this phenotype
has remained obscure. Here, we have isolated LINT, a novel
protein complex containing dL(3)mbt, the corepressor
dCoREST, and the uncharacterised protein dLint-1. We
have used genome-wide ChIP–Seq analysis to map the
binding sites of LINT. LINT occupies the promoters of many
genes that are deregulated in l(3)mbt brain tumours,
suggesting that these genes are repressed by LINT. Indeed,
RNAi–mediated depletion of LINT subunits results in the
derepression of these genes. Surprisingly, LINT-mediated
repression is largely independent of histone modification
status, arguing for a repression mechanism that operates
by restricting promoter access.
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extensive colocalisation between both proteins. We visually
assessed 466 bands for dL(3)mbt and dLint-1 binding (see
Methods). 83% of these were stained by both antibodies, 12%
showed dLint-1 but no or very weak dL(3)mbt binding and 5%
appeared to be bound by dL(3)mbt only. These results show that
dL(3)mbt and dLint-1 can cooccupy many chromatin regions on
polytene chromosomes suggesting that these two proteins not only
associate in soluble nuclear extracts but also when bound to
chromatin.
Figure 1. dLint-1 is a novel dL(3)mbt–interacting protein. (A) Nuclear extract from Kc cells was fractionated over a Superose 6 column.
Fractions were analyzed by Western blot using the antibodies indicated. Fraction numbers and molecular mass standards are denoted on top. Input:
5% of extract loaded. (B) Nuclear extracts from control S2 cells (mock, lanes 1 and 3) and S2 cells stably expressing FLAG-dL(3)mbt (lanes 2 and 4)
were subjected to FLAG affinity purification, elution with FLAG peptide, SDS-PAGE and silver staining (lanes 3 and 4). Input: 2 mg of nuclear extracts
(lanes 1 and 2). The positions of FLAG-dL(3)mbt and dLint-1 are indicated on the right. (C) In vitro translated,
35S-labeled dLint-1 (upper panel) or
luciferase (lower panel) were incubated with FLAG beads (beads, lane 3) or beads loaded with FLAG-dL(3)mbt (lane 2). Bound proteins were
separated by SDS-PAGE and detected by autoradiography. Lane 1: 1% input. (D) Sf9 cells were infected with baculoviruses expressing dL(3)mbt-FLAG
or dLint-1 as indicated on top. Extracts were immunoprecipitated and subjected to Western blot using FLAG and dLint-1 #2 antibodies (lanes 2, 4
and 6). Lanes 1, 3 and 5: 5% input. (E) Nuclear extracts from control S2 cells (mock, lanes 1 and 3) and S2 cells stably expressing dLint-1-FLAG (lanes 2
and 4) were subjected to FLAG affinity purification, elution with FLAG peptide, SDS-PAGE and silver staining (lanes 3 and 4). Input: 2 mg of nuclear
extracts (lanes 1 and 2). The position of dLint-1-FLAG and copurifying proteins are indicated on the right. * denotes that eIF-4B was also recovered
from the control and is considered to be a contaminant. Note that dCoREST and dLsd1 have the same molecular weight and comigrate. (F) Nuclear
extracts from control S2 cells (mock, lanes 1 and 2) and S2 cells stably expressing FLAG-dLint-1 (lanes 3 and 4) were precipitated with FLAG antibody
and analyzed by Western blot as indicated (lanes 2 and 4). dPR-Set7 served as a negative control. Lanes 1 and 3: 5% input.
doi:10.1371/journal.pgen.1002676.g001
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PLoS Genetics | www.plosgenetics.org 3 May 2012 | Volume 8 | Issue 5 | e1002676Figure 2. Purification of the LINT complex. (A) Nuclear extracts of Kc cells treated with dsRNA directed against EGFP (control, lanes 1 and 3) and
dLint-1 (lanes 2 and 4) were subjected to Western blot using dLint-1 antibody #1 (left upper panel), dLint-1 antibody #2 (right upper panel) and
tubulin antibody (lower panels). (B) Nuclear extracts from Kc cells were precipitated with protein G beads (beads control, lane 3) and beads loaded
with dLint-1 #1 antibody (lane 2) and analyzed by Western blot as indicated (lanes 2 and 3). dMi-2 served as a negative control. Lane 1: 5% input; lane
4 contains dLint-1 antibody (antibody control). * denotes a polypeptide that unspecifically crossreacts with the dLsd1 antibody (compare lanes 2 and
4). (C) Nuclear extract from Kc cells was fractionated over a Superose 6 column. Fractions were analyzed by Western blot. Fraction numbers and
molecular mass standards are denoted on top. Input: 5% of extract loaded. (D) Kc nuclear extract was separated by sequential ion exchange
chromatography over Q-Sepharose and MonoQ columns. MonoQ fractions were analyzed by Western blot as indicated. Fraction numbers are
denoted on top. (E) Extract from third instar larval brains was precipitated with protein G beads (beads control, lane 3) and beads loaded with dLint-1
antibody (lane 2) and analyzed by Western blot as indicated (lanes 2 and 3). Lane 1: 5% input; lane 4 contains dLint-1 antibody (antibody control). *
denotes a polypeptide that unspecifically crossreacts with the dLsd1 antibody (compare lanes 2 and 4).
doi:10.1371/journal.pgen.1002676.g002
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ts brain
tumours
We next performed a ChIP-Seq analysis to determine genome-
wide binding sites of dLint-1 in Kc and S2 cells. dLint-1 binding
sites identified in the two cell lines showed a high correlation even
though they represent different cell types (Pearson correlation
0.81; Figure S4). This suggests that many dLint-1 binding sites are
conserved across cell types. The majority of dLint-1 binding sites
in S2 cells map to a 250 bp region surrounding transcriptional
start sites (TSSs) (2200 to +50, Figure 4A and Figure S5A). More
than half of the dLint-1 peaks overlap with a TSS (Figure S5B).
This suggests that dLint-1 is preferentially associated with
promoter regions indicating a potential role in transcription
regulation.
We included dL(3)mbt ChIP-Seq data from larval brain
reported by Richter and colleagues in our analysis to determine
the extent of overlap between dL(3)mbt and dLint-1 binding [4].
Of the 2902 dL(3)mbt peaks defined in this study, 2347 (80.1%)
overlapped with dLint-1 peaks. Although we are comparing
dL(3)mbt binding sites in larval brain tissue with dLint-1 binding
sites in S2 cells, these results strongly suggest that dL(3)mbt and
dLint-1 bind together to many sites within the genome.
Two recent studies have implicated the derepression of MBTS
genes with a germline function and genes targeted by the SWH
pathway, respectively, in the formation of brain tumours in l(3)mbt
mutant larvae [3,4]. dL(3)mbt associates with many of these genes
in larval brain [4]. To determine whether LINT binds these genes
as well we compared dL(3)mbt and dLint-1 binding profiles.
Figure 4B shows dLint-1 and dL(3)mbt binding profiles at regions
containing the MBTS germline genes zero population growth
(zpg) and hold’em (hdm). In both cases, dL(3)mbt and dLint-1
cooccupy sequences overlapping with promoter and TSS.
Inspection of all 32 MBTS germline genes derepressed in l(3)mbt
tumours revealed that 25 are bound by dL(3)mbt in larval brain
and dLint-1 in both Kc and S2 cells (Table S1). We also assessed
dCoREST binding to germline-specific genes by ChIP-qPCR
(Figure 4D). Like dLint-1, dCoREST binding peaks at the
promoter regions of germline genes. Comparison of the dL(3)mbt
and dLint-1 binding profiles in regions containing the 11 SWH
target genes analyzed by Richter et al. revealed that 6 SWH targets
are cooccupied by dL(3)mbt and dLint-1 (Figure 4C and Table
S1). Taken together these results suggest that the LINT complex
binds to the promoter regions of a majority of MBTS germline and
SWH target genes that are deregulated in l(3)mbt
ts tumours.
LINT represses MBTS genes with germline function
To assess if LINT binding to MBTS germline and SWH target
genes is functionally relevant we determined changes in the gene
expression profile of Kc cells following RNAi-mediated depletion
of dL(3)mbt and dLint-1, respectively (Figure 5A). Microarray
analysis identified 563 genes that were deregulated by both RNAi
treatments (Figure 5B). 460 (81,7%) of these were upregulated
suggesting that LINT functions predominantly to repress tran-
scription.
In this experiment none of the 11 SWH target genes was found
to be derepressed in dL(3)mbt or dLint-1 depleted Kc cells (Table
S2). By contrast, 15 of the 32 MBTS genes with a germline
function were upregulated in both dL(3)mbt and dLint-1-depleted
cells (Table S2). Moreover, the MBTS germline genes piwi, nos,
swa, hdm, RbS5b and CG32313 were among the top 50 genes that
were most strongly derepressed in both dL(3)mbt and dLint-1
depleted cells (Table S3). Furthermore, 20 of the top 50 genes
encode proteins with a testis- or ovary-specific expression pattern
(Table S3).
We sought to determine if RNAi depletion of dL(3)mbt and
dLint-1 would also lead to derepression of genes with germline
function in developing larvae of transgenic flies. Figure 5C shows
that depletion of either LINT subunit resulted in derepression of
piwi, nos, swa, ea and tor. These results suggest that dL(3)mbt and
dLint-1 play important roles in the repression of many genes with
a germline-specific expression pattern both in cell lines and in the
developing fly.
Given that our biochemical analyses had suggested that dLint-1
and dCoREST in addition to being core components of LINT also
associate with the histone modifying enzymes dLsd1 and dRpd3
we considered the role of histone modifications in the repression of
MBTS germline genes. We derepressed the MBTS germline genes
swa and nos by RNAi-mediated depletion of dL(3)mbt in Kc cells
Figure 3. dL(3)mbt and dLint-1 colocalise on polytene chromosomes. (A) Immunofluorescence stainings of polytene chromosomes. Flies
carrying an dL(3)mbt transgene under control of UAS were crossed with a salivary gland-specific sgs58AB-GAL4 driver strain. Polytene chromosomes
were stained with dL(3)mbt, dLint-1 antibodies and DAPI as indicated. The right panel shows an overlay of the dL(3)mbt and dLint-1 staining. (B)
Magnified sections of the panels shown in (A). White and grey arrow heads denote selected prominent sites of colocalization (white) and exclusive
dLint-1 binding sites (grey), respectively.
doi:10.1371/journal.pgen.1002676.g003
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PLoS Genetics | www.plosgenetics.org 5 May 2012 | Volume 8 | Issue 5 | e1002676Figure 4. LINT binds to genes deregulated in l(3)mbt
ts brain tumours. (A) Averaged dLint-1 ChIPseq signal intensity around those
transcription start sites that are within 1 kilobase of a dLint-1 peak (normalized to 1 million tags). In cases where multiple TSSs were within 1 kb of a
peak, the one with the smallest summit-TSS distance was chosen. (B) Genome browser view of dLint-1 and dL(3)mbt [4] chromatin association in
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and 6B). Derepression of both genes correlated with increased
H3K4me2 ChIP signals in both promoter and coding regions. To
test if the H3K4me1/2-specific demethylase dLsd1 might be
involved in maintaining low H3K4me2 levels at the repressed swa
and nos genes we depleted dLsd1 by RNAi (Figure 6A). However,
this did not result in increased H3K4me2 levels (Figure 6B).
We also tested if depletion of dLsd1 or dRpd3 would be
sufficient to derepress LINT target genes (Figure 6C). RNAi-
mediated depletion of dL(3)mbt, dLint-1 or dCoREST resulted in
strong derepression of 7 out of 8 MBTS germline genes tested. By
contrast, depletion of dLsd1 or dRpd3 had no significant effect.
We conclude that derepression of MBTS germline genes can be
achieved by depletion of any of the three LINT core components
but not by depletion of dLsd1 or dRpd3.
dL(3)mbt binds H4K20me1/2 via its MBT domains in vitro [14].
To test if H4K20 methylation contributes to LINT target gene
repression we depleted the H4K20-specific methylase dPR-Set7
(Figure 6D). While RNAi treatment resulted in robust depletion of
dPR-Set7 and global reduction on H4K20me1 levels, expression
of LINT target genes was not affected (Figure 6D and 6E).
We also assessed H4K20me1 and H4K20me2 levels at LINT
target genes by ChIP-qPCR (Figure 6F). We used the actin gene as
a postive control to verify the efficiency of the ChIP. Indeed,
regions containing MBTS genes (upper panel: zpg, lower panel: hdm). (C) Genome browser view of dLint-1 and dL(3)mbt [4] chromatin association in
regions containing SWH target genes (upper panel: CycB, lower panel: diap-1). (D) Chromatin immunoprecipitation (ChIP) of Kc cell chromatin using
dLint-1 #1 and dCoREST antibodies. As a control chromatin was precipitated with ProtG beads loaded with pre-immune serum or no antibody
(beads). Genes analyzed are denoted below the panel. Amplified regions are indicated by boxed letters and had the following distances from the TSS
as illustrated below: a, 3 kb upstream; b, 1.5 kb upstream; c, 0–0.15 kb (promoter); d, 1.5 kb downstream.
doi:10.1371/journal.pgen.1002676.g004
Figure 5. LINT represses MBTS genes with germline function. (A) Gene expression analysis upon RNAi mediated depletion of dL(3)mbt and
dLint-1 in Kc cells. Kc cells were treated with double-stranded RNA (dsRNA) directed against EGFP, dL(3)mbt or dLint-1. Nuclear extracts were
analyzed by Western blot as indicated. (B) Venn diagrams of dL(3)mbt and dLint-1 regulated genes (fold change $1.5, adj. p#0.05). (C) Target gene
expression upon depletion of dL(3)mbt and dLint-1 in flies. RNAi depletion was achieved by crossing the da-GAL4 driver strain to w
1118 (control) and
strains carrying dL(3)mbt or dLint-1 RNAi transgenes under UAS control, respectively. RNA was isolated from 3rd instar larvae and transcription was
determined by RT-qPCR. Transcription levels in control crosses were set to 1. Tudor serves as a negative control.
doi:10.1371/journal.pgen.1002676.g005
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PLoS Genetics | www.plosgenetics.org 8 May 2012 | Volume 8 | Issue 5 | e1002676robust H4K20me1 levels were detected at the actin gene (Figure 6F,
left panel). By comparison H4K20me1 levels at the swa and nos
promoters, which bind LINT, were approximately 20-fold lower.
H4K20me1 ChIP signals at swa and nos were comparable to
signals at an intergenic region that we used as a negative control.
Moreover, H4K20me1 ChIP signals at swa and nos were not
significantly different than signals obtained with the IgG control
IP. RNAi-mediated dPR-Set7 depletion resulted in a strong
reduction of H4K20me1 levels at the actin gene but did not affect
H4K20me1-levels at swa and nos. We confirmed these results using
an independent H4K20me1-specific antibody (Figure S6). We
conclude that H4K20me1 appears to be absent from the LINT-
bound swa and nos promoters.
H4K20me2 is the most abundant form of histone H4 both in
Drosophila and mammals accounting for 85–90% of total H4
[10,11]. Accordingly, ChIP using a H4K20me2-specific antibody
produced robust ChIP signals for all four regions tested (Figure 6F,
right panel). Depletion of dPR-Set7 reduced H4K20me2 levels at
all regions. H4K20me2 levels differed by a factor of less than 3
between swa, nos, actin and the intergenic region. In fact, the LINT-
complex bound swa and nos promoters displayed the lowest
H4K20me2 levels of the four. We conclude that H4K20me2 is
detectable at LINT target genes. However, presumably due to the
abundance of this modification it is uniformely high along the
chromosome and also present at control regions that do not bind
LINT.
Taken together, these results suggest that the LINT core
subunits - but not the histone modifying enzymes dLsd1, dRpd3
and dPR-Set7 - are required to maintain the repression of many
germline-specific genes in cell lines and in developing flies.
Changes in H3K4 methylation levels detected at the swa and nos
genes are likely to be a consequence of derepression rather than its
cause. In addition, our data do not support an important role of
H4K20 methylation in the targeting of LINT to promoters.
Given that LINT-mediated repression appears to be largely
independent of histone modifying activities and given that LINT
displays a strong preference for binding around the TSS, an
alternative repression mechanism could be based on restricting
transcription factor and/or RNA polymerase II access to promoter
sequences. To test this hypothesis, we recruited LINT subunits to
the promoter of a reporter gene (Figure 7A). Indeed, recruitment
of a dL(3)mbt- or a dLint-1-LexA fusion protein to a luciferase
reporter gene driven by a LexA site containing promoter resulted
in robust, dosis-dependent repression. To test the involvement of
histone modifications in this system we RNAi depleted subunits of
histone modifying complexes with an established role in
transcriptional repression (Figure 7B). dLsd1, G9a, Pc, E(z),
Suz(12) and dRING did not abrogate repression of the reporter or
repression of MBTS germline genes (Figure 7B and data not shown).
By contrast, depletion of the three LINT subunits dL(3)mbt, dLint-
1 and dCoREST resulted in partial derepression suggesting that
the presence of all three subunits at the promoter is required for
efficient transcriptional repression.
Discussion
We have identified and characterized LINT a novel dL(3)mbt
complex that represses a set of germline-specific genes that is
deregulated in malignant tumours of the larval brain. LINT has
three core subunits, dL(3)mbt, dLint-1 and dCoREST, all three of
which are required to maintain repression of germline-related
MBTS genes in cell lines and larvae.
LINT subunit composition differs from the human L3MBTL1
complex which contains pRb, HP1c, H1b and core histones
(Figure 8). dLint-1 has no apparent homolog in mammals. The
mammalian homologs of dCoREST exist in complexes containing
LSD1 and HDAC1/2. dLsd1 and dRpd3 are not stably associated
with LINT. Nevertheless, the LINT subunit dLint-1 associates
with dCoREST, dLsd1 and dRpd3 arguing for the existence of
complexes in Drosophila that are related to mammalian CoREST/
LSD1 complexes. Two observations are consistent with the view
that these complexes might associate with chromatin and occupy
sites that are not bound by LINT. First, dLint-1 is associated with
approximately 50 bands on polytene chromosomes that show no
dL(3)mbt binding. Second, ChIP-Seq analysis has revealed 2,902
dL(3)mbt binding sites but more than 8,000 dLint-1 binding sites.
The functional relationship between these different dLint-1-
containing complexes is unclear.
Comparison of genomewide binding profiles of dL(3)mbt in
larval brain and dLint-1 in S2 and Kc cells strongly argues that
LINT subunits bind to a large set of common binding sites. In
particular, MBTS germline-related genes are bound and often
repressed by the three LINT subunits. Our finding that LINT
exists in larval brain strongly implies that it is the LINT complex
that is inactivated in l(3)mbt
ts mutants. In addition to MBTS genes,
genes targeted by the SWH pathway have recently been shown to
be deregulated in l(3)mbt
ts brains [4]. Although we have detected
binding of dLint-1 to about half of the SWH targets, we have not
detected changes in SWH target gene expression following
depletion of dL(3)mbt or dLint-1 in Kc cells. It is possible that
protein depletion was not sufficient to derepress these genes under
our conditions. Also, SWH target genes might be regulated
differently in larval brain compared to cell lines.
Our results suggest that maintenance of MBTS germline gene
repression by LINT is largely independent of repressive histone
modifying activities. Depletion of the dLint-1-associated dLsd1
and dRpd3 enzymes does not lead to derepression of LINT
targets. We detected an increase of the active H3K4me2 mark at
derepressed LINT target genes but this is most likely a result of
active transcription rather than a direct consequence of the loss of
LINT associated chromatin modifying activities. In agreement
with this view, depletion of dLsd1 does not result in changes of
H3K4me2 levels at LINT target genes. Our microarray analysis
Figure 6. dLsd1, dRpd3, and dPR-Set7 are not essential for MBTS gene repression. (A) Kc cells were treated with dsRNA directed against
EGFP, dL(3)mbt and dLsd1. Nuclear extracts of RNAi treated Kc cells were subjected to Western blot and analyzed using antibodies as indicated. (B)
Chromatin of RNAi treated cells was precipitated with H3K4me2 and H3 antibodies as indicated. The ratio of H3K4me2 and H3 ChIP signals is shown
for swa and nos promoter and ORF regions and an unrelated intergenic region (interg.). Genes analyzed are denoted below the panel. Amplified
regions are indicated by boxed letters and have the following distances from the transcriptional start site as illustrated on the right: c, 0–0.15 kb
(promoter); d, 1.5 kb downstream. (C) Kc cells were treated with dsRNA directed against EGFP, dL(3)mbt, dLint-1, dRpd3, dCoREST and dLsd1 as
indicated and transcription was determined by RT-qPCR. Transcription levels in EGFP RNAi treated cells were set to 1. Tudor serves as a negative
control. (D) Kc cells were treated with dsRNA directed against EGFP and dPR-Set7 as indicated. Nuclear extracts and acid extracted histones were
analyzed by Western blot as indicated. (E) Transcription levels of target genes were determined by RT-qPCR. Transcription levels in cells treated with
dsRNA against EGFP were set to 1. (F) Chromatin from cells treated with RNAi against dPR-Set7 or EGFP (control) was precipitated with H4K20me1
and IgG (left panel) or H4K20me2 and IgG (right panel) antibodies as indicated. ChIP signals are shown for swa and nos promoter regions, an
intergenic region and the actin gene as denoted below the panel.
doi:10.1371/journal.pgen.1002676.g006
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recently shown to be repressed by dLsd1 in S2 cells and developing
flies [12,13]. This suggests that LINT and dLsd1 target different
sets of genes.
Chromatin association and the repressive potential of human
L3MBTL1 is enhanced by PR-SET7 and H4K20 monomethyla-
tion [5,6]. Depletion of dPR-Set7, the sole Drosophila enzyme
responsible for H4K20 monomethylation, did not result in
derepression of LINT targets. We also did not detect significant
levels of H4K20me1 at promoters of LINT target genes. This
strongly suggests that even though dL(3)mbt can bind H4K20me1
in vitro this interaction does not play an important role in LINT
complex targeting and repression.
dL(3)mbt does also bind to H4K20me2 in vitro. Indeed,
H4K20me2 is present at LINT-regulated genes. However,
H4K20me2 levels are are not elevated at LINT target gene
promoters compared to control regions. This finding was not
surprising given that 85–90% of all histone H4 molecules are
dimethylated at K20 and, therefore, H4K20me2 levels might be
expected to be uniformely high along the chromosome [10,11].
This makes it unlikely that an interaction between the MBT
domains and H4K20me2 specifically directs the LINT complex to
its target genes. However, it remains possible that after recruit-
ment of LINT by other means, an interaction between dL(3)mbt
and H4K20me2 contributes to transcriptional repression.
Depletion of other enzymes setting repressive histone marks
such as H3K9me3 and H3K27me3 has likewise no effect on
LINT-mediated repression. Although we have not been able to
test all histone modifying enzymes for their roles in LINT target
gene repression, the results argue for a largely histone modification
Figure 7. Promoter recruitment of LINT subunits results in transcriptional repression. (A) A Firefly luciferase reporter construct (schematic
representation on top) was transiently cotransfected into RNAi treated Kc cells along with a Renilla luciferase reporter and varying amounts of
expression vectors for LexA or dL(3)mbt-/dLint-1-LexA fusion proteins as indicated. Repressor activities of dL(3)mbt-LexA and dLint-1-LexA are
presented as -fold repression normalized against activities measured for LexA expression alone. (B) Kc cells were treated with no dsRNA (mock) or
dsRNA against EGFP, dL(3)mbt, dLint-1, dCoREST, dLsd1, G9a and Pc. Cells were then cotransfected with reporter and expression vectors as in (A).
doi:10.1371/journal.pgen.1002676.g007
Figure 8. L(3)mbt and LSD1/CoREST complexes. Schematic representation of complex composition of mammalian L3MBTL1 (left), Drosophila
LINT (middle) and mammalian LSD1/CoREST (right) complexes [5,21,22]. Only core subunits are shown. Shared homologous subunits are indicated by
color (red: L(3)mbt, blue: CoREST). Proposed repression mechanisms for each complex are indicated below.
doi:10.1371/journal.pgen.1002676.g008
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nantly near TSSs suggesting that LINT might inhibit transcription
by restricting the access of RNA polymerase II or transcription
factors to promoters. In support of this model, recruitment of
LINT subunits to the promoter of a reporter gene is sufficient for
repression even under conditions where the levels of repressive
histone modification enzymes are reduced. We can envisage two
modes of promoter access restriction by LINT that are not
mutually exclusive. First, LINT might bind to the promoter
segments required for RNA polymerase II recruitment. Second, as
has been suggested for human L3MBTL1, LINT might locally
compact nucleosomes. Two of our findings are inconsistent with
the latter hypothesis. Nucleosome compaction by L3MBTL1 is
dependent on the presence of the H4K20me1 modification.
However, as discussed above, ablation of this modification does
not result in derepression of LINT target genes. In addition, as a
consequence of nucleosome compaction at LINT bound promot-
ers one might expect a local increase in nucleosome density.
However, histone H3 ChIP experiments have shown that the
promoters of LINT target genes are generally depleted of
nucleosomes (data not shown). While these findings do not rule out
a local nucleosome compaction that is - once established -
independent of H4K20 monomethylation and undetectable by H3
ChIP, we favour the simpler hypothesis that LINT association
with promoter sequences prevents transcription factors and RNA
polymerase II from promoter binding (Figure 8).
The dL(3)mbt and dCoREST subunits of LINT are well
conserved. Similar to the derepression of germline-related genes in
l(3)mbt
ts tumours, misexpression of testis-specific genes (so-called
cancer testis antigens) have been described in many human
tumours [14]. Based on our study, it is conceivable that L3MBTL1
or CoREST play a role in the repression of cancer testis antigens.
Materials and Methods
Cell culture, transfections, RNAi treatments, and
baculovirus infection
D. melanogaster and S. frugiperda cell lines were maintained under
standard conditions. Transfection of Kc cells for the luciferase
reporter assay was carried out according to the manufacturer’s
instructions (Qiagen). RNA interference and baculovirus infection
were described in [15].
Antibodies
Rabbit polyclonal and rat monoclonal (MBT P1 6E6) anti-
dL(3)mbt, rabbit polyclonal anti-dMi-2 (anti-dMi2-Nterm) and
anti-dRpd3 antibodies have been previously described [16,17].
Rabbit dL(3)mbt antibody was used in Western blot and
monoclonal dL(3)mbt antibody was used for immunostainings.
dCoREST (G. Mandel), dSu(var)3-3 (dLsd1, T. Rudolph), dPR-
Set7 (A. Imhof) and RBF2 (N. Dyson) antibodies were generous
gifts. anti-beta-Tubulin (clone KMX-1) antibody was from
Millipore, anti-FLAG M2 antibody and agarose from Sigma.
Histone antibodies were purchased from the following companies:
Abcam: anti-H4K20me1 (#9051); anti-H3 (#1791); Millipore:
anti-H4K20me1 (#17-651); anti-H3K4me2 (clone CMA303,
#05-1338); Active Motif: anti-H4K20me2 (#39173). Anti-dLint-
1 antibodies were developed in this study (Figure 2A). Anti-dLint-1
#1 antibody was used for immunoprecipitation, immunostaining
and ChIP analysis. Anti-dLint-1 #2 antibody was used for
immunoblotting.
To generate Lint-1-specific antibodies, the C-terminus (aa 302–
602) of dLint-1 was fused to GST by cloning into pGex4T1 vector.
The recombinant protein was expressed in E. coli BL21 according
to standard procedures. The GST-Lint-1-C-term fusion protein
was purified via affinity chromatography using a GSTrap FF
column (GE Healthcare) and subsequent ion exchange chroma-
tography using a HiTrap SP HP column (GE Healthcare) on an
A ¨kta purifier system (GE Healthcare) according to the manufac-
turer’s instructions. For immunization two rabbits (serum #1 and
#2) were injected with 0.5 mg of purified GST-Lint-1-C-term
fusion protein each (Peptide Speciality Laboratories, Heidelberg,
Germany). The specificity of antibodies was verified by RNA
interference in Kc cells and subsequent Western blot analysis of
nuclear extracts (Figure 2A).
Immunostaining and immunoblotting
The following antibodies were used: Primary antibodies: anti-
dL(3)mbt P1 6E6 (rat, concentrated) 1:2 and dLint-1 #1 (rabbit)
1:50. Secondary antibodies: Alexa Fluor 546 goat anti-rat and
Alexa Fluor 488 goat anti-rabbit 1:200 (Invitrogen). Analysis was
performed with a Zeiss fluorescence microscope (Axioplan).
Quantitative analysis of dL(3)mbt and dLint-1 binding sites was
accomplished by visual inspection using Image J software (http://
rsbweb.nih.gov/ij/). Western blots were carried out as previously
described [16].
Transgenic fly lines and polytene chromosomes
Transgenic fly lines were generated and polytene chromosomes
were analyzed by immunofluorescence as described in [18]. RNA
interference experiments in flies were performed using stocks from
the VDCR phiC31 RNAi Library (http://stockcenter.vdrc.at/
control/main) carrying RNAi transgenes under UAS control
(transformant IDs: dL(3)mbt: 104563; dLint-1: 105932). For
overexpression or knockdown experiments the GAL4-driver strains
da-GAL4 and sgs58AB-GAL4 were used, respectively. As control,
GAL4-driver strains were crossed with the host strain w
1118.
Expression of recombinant proteins
dL(3)mbt and dLint-1 cDNA was obtained from BDGP (clone
LD05287 of dL(3)mbt and RE35228 of dLint-1). Vectors for
expression of N-terminally FLAG-tagged dL(3)mbt and C-
terminally FLAG-tagged dLint-1 in S2 cells were generated by
PCR-cloning of the respective ORFs in either pPac-HA-FLAG or
pPac-FLAG-Back vector using gene specific primers. Generation
of S2 cell lines stably expressing recombinant dL(3)mbt and dLint-
1 was performed as described previously [17]. To obtain
recombinant dL(3)mbt-FLAG and dLint-1 baculovirus transfer
vectors ORFs were cloned into pVL1392 using appropriate sets of
primers. Baculovirus production and purification have been
previously described [16].
Interaction assay of in vitro translated
35S labeled dLint-1
and baculoviral expressed FLAG–dL(3)mbt
The dLint-1 coding region was inserted into pING14A. In vitro
translation of dLint-1 and a luciferase control in the presence of
35S-methionine was carried out with the TNT SP6 Coupled
Reticulocyte Lysate System (Promega) according to the manufac-
turer’s instructions. FLAG-tagged dL(3)mbt was expressed in Sf9
cells using the baculovirus system. 12 ml of Sf9 extracts, were
bound to 60 ml of anti-FLAG M2 agarose (Sigma) and washed
extensively with LyBu200 and LyBu500 buffer (20 mM Hepes
pH 7.6, 200 mM or 500 mM KCl, 10% glycerol, 0.1% NP-40,
1 mM DTT and protease inhibitors). 10 ml of anti-FLAG beads
were blocked with 0.2 mg/ml BSA for 30 min and incubated with
8 mlo f
35S-dLint-1 or 6 mlo f
35S-Luciferase for 3 hours each in IP
buffer (25 mM Hepes, pH 7.6, 12.5 mM MgCl2, 0.1 mM EDTA,
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extensive washing with IP buffer samples were separated by SDS-
PAGE and treated with Amplify (Amersham) according to
manufacturer’s instructions. The gel was dried and subjected to
autoradiography.
Extract preparation, histone extraction, and
immunoprecipitations
Nuclear extract from Kc and S2 cells and whole cell extracts
from Sf9 cells were prepared and immunoprecipitations were
carried out as described elsewhere [16]. For extraction of histones
the insoluble nuclear pellet was resuspended in 0.4 M HCl and
incubated overnight at 4uC with shaking. After centrifugation (at
4uC, 15 min, 13000 rpm) extracted histones were in the superna-
tant. For larval brain extracts, brains were resuspended in LNBI
buffer (15 mM Hepes/KOH, pH 7.6, 10 mM KCl, 5 mM
MgCl2, 0.1 mM EDTA, pH 8.0, 350 mM sucrose, 1 mM DTT,
protease inhibitors), homogenized and incubated for 10 min on
ice. The tissue suspension was then centrifuged, nuclei were
resuspended in LNBII buffer (15 mM Hepes/KOH, pH 7.6,
385 mM KCl, 5 mM MgCl2, 0.1 mM EDTA, pH 8.0, 0.1%
Tween 20, 10% glycerol, 1 mM DTT, protease inhibitors),
incubated for 30 min on ice and centrifuged. LNBI and LNBII
extracts were pooled and used for immunoprecipitation. For
immunoprecipitation 750 mg of nuclear extract (from Kc cells or
0–12 h embryos) or protein extract from 200 brains were
incubated with 1.5 ml dLint-1 #1 antibody diluted with IP buffer
or PBS, respectively, to a final salt concentration of 200 mM, and
incubated for 2 h to 3 h at 4uC with rotation. 5 ml of Protein G
beads (GE Healthcare) were added and incubation was continued
for 1 h. Following extensive washing with IP buffer or PBS,
immunoprecipitates were analyzed by Western blot. FLAG-
immunoprecipitations were carried out with S2 nuclear extracts
(750 mg total protein) and 5 ml anti-FLAG M2 agarose (Sigma),
diluted with IP buffer to a final salt concentration of 200 mM.
Incubation was performed for 3 h at 4uC with rotation. After
extensive washing with IP buffer beads were analyzed by Western
blotting. 200 ml of whole cell extracts of baculovirus-infected Sf9
cells were incubated in 800 ml IP buffer with 10 ml anti-FLAG M2
agarose for 3 h at 4uC with rotation. Beads were washed
extensively with IP buffer and analyzed by Western blotting.
Complex purification
For FLAG affinity purification of FLAG-dL(3)mbt and dLint-1-
FLAG associated proteins, nuclear extracts from stable S2 cell
lines were prepared, as described before. 70 mg (total protein) of
FLAG-dL(3)mbt extract and 150 mg (total protein) of dLint-1-
FLAG extract, as well as an equal amount of S2 mock extract were
incubated with 60 or 120 ml FLAG M2 agarose (Sigma-Aldrich;
equilibrated in D-125/10) respectively in D-125 (D-x: 20 mM
HEPES/KOH pH 7.6, x mM KCl, 2 mM MgCl2, 0.2 mM
EDTA, 0.05% NP40, 10% glycerol, protease inhibitors) buffer at
4uC for 3 hr with rotation. FLAG-beads were washed once with
buffer D-125, three times with D-300 and once with D-125. Each
wash was carried out with 10 ml of buffer at 4uC for 10 min on a
rotating wheel. Bound proteins were eluted with 0.4 mg/ml
FLAG-peptide (Sigma-Aldrich) in D-125 buffer. The beads were
diluted 1:1 in elution buffer and elution was carried out for 2 hr on
ice with regular mixing of the slurry. Additionally, an elution was
performed overnight at 4uC on a shaker. Eluates were combined,
precipitated using StrataClean resin (Stratagene), subjected to
SDS-PAGE and visualized by silver or Colloidal Coomassie Blue
(Invitrogen) staining. In general, 10% of the eluates were
visualized by silver staining, whereas 90% were loaded onto a
gel for Colloidal Coomassie Blue staining. Protein bands were
excised from Colloidal Coomassie Blue stained gels and analyzed
by peptide mass fingerprinting (Zentrum fu ¨r Proteinanalytik,
Munich, Germany).
Ion exchange chromatography (IEX) was carried out according
to standard procedures on an A ¨kta purifier system with a Frac-950
fraction collector using columns supplied by GE Healthcare
according to the manufacturer’s instructions. Kc nuclear extract
was diluted 4.26with IEX-0 buffer (20 mM Tris/HCl pH 7.5, x
mM NaCl, 1 mM DTT, PMSF) to adjust the NaCl concentration
of the sample to 100 mM. Subsequently, the sample was bound to
a HiTrap Q Sepharose FF column (1 ml volume), that was prior to
this equilibrated with IEX-100 buffer. The flow through was
loaded once more to ensure efficient binding of proteins. Then the
column was washed with 5–10 ml of IEX-100 buffer or until no
protein (measured by absorption at 280 nm) appeared in the
effluent. Elution was performed in two steps: First, applying IEX-
500 buffer and second, applying IEX-1000 buffer. Peak fractions
of the eluates were collected and tested together with the flow
through by Western blotting. Next, the eluate (IEX-500 peak),
containing the proteins of interest, was diluted 56 with IEX-0
buffer. The sample was then bound to a Mono Q 5/50 GL
column (GE Healthcare) and after the application the column was
washed with 5–10 ml of IEX-100 buffer or until no protein was
present in the effluent. For elution a continuous salt gradient was
used, going from 100 mM up to 500 mM NaCl in IEX buffer,
applied at a flow rate of 1 ml/min, collecting 50 fractions each of
0.5 ml volume. Finally, residual protein was eluted in one step
with IEX-1000 buffer. 500 ml fractions were collected, precipitated
using StrataClean resin (Stratagene) and subjected to Western blot
analysis.
Luciferase assay
Kc cells were treated with dsRNA for 48 hours. Then cells were
transfected with the following expression vectors using Attractene
tranfection reagent (Qiagen): 1. 1 mg of pAc5.1-LexA, pAc5.1-
dL(3)mbt-LexA or pAc5.1-dLint-1-LexA; 2. 250 ng of pGL2-hse/
lexA; 3. 100 ng of pPacRNLuc. 48 hours after transfection, Firefly
and Renilla luciferase activities were measured using the Dual-
Luciferase Reporter Assay System (Promega) according to
manufacturer’s instructions. For each sample the mean from
triplicate measurements Firefly and Renilla Luciferase activity and
standard deviations were determined. Firefly Luciferase activity
was normalized against Renilla Luciferase activity to control for
variation in transfection efficiency. Repressive activity (fold
repression) was determined by relating luciferase values obtained
after expression of LexA fusion proteins to luciferase values
obtained after expression of LexA alone.
qRT–PCR
Total RNA from Kc cells or 3rd instar larvae was isolated using
the peqGOLD total RNA kit (Peqlab). 1.5 mg of RNA was applied
to RT by incubation with 0.5 mg of Oligo(T)17 primer and 100 U
of M-MLV reverse transcriptase (Invitrogen). cDNA was analyzed
by qPCR, which was performed using Absolute SybrGreen Mix
(Thermo Fisher) and the Mx3000P real-time detection system
(Agilent). All amplifications were performed in triplicates using
0.6 ml of cDNA per reaction. Triplicate mean values were
calculated according to the DDCT quantification method using
GAPDH1 transcription as normalisation reference. Standard
deviation was calculated from triplicates, error bars are indicated
accordingly. Relative mRNA levels in EGFP RNAi treated Kc
cells or control flies were set to 1 and other values were expressed
relative to this.
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ChIPs were performed as described in the Upstate Biotechnol-
ogy ChIP assay protocol. 100*10
6 Kc cells were fixed in 1%
formaldehyde for 10 min at RT. Fixation was stopped by the
addition of 240 mM glycine. Cells were harvested, washed in ice
cold PBS, resuspended in 1 ml SDS-Lysis buffer (50 mM Tris-
HCl, pH 8.0, 10 mM EDTA, 1% SDS, protease inhibitors) and
incubated for 10 min on ice. Lysates were sonicated using a
Bioruptor (Diagenode) to obtain an average fragment length of
0.5 kb and centrifuged (at 4uC, 15 min, 13000 rpm). Shearing of
the DNA was analyzed by agarose gel electrophoresis following
reversal of crosslinks. The supernatant (chromatin) was subjected
to ChIP analysis. 140 ml of chromatin were used per ChIP, diluted
106with IP-buffer (16.7 mM Tris-HCl, pH 8.0, 16.7 mM NaCl,
1.2 mM EDTA, 0.01% SDS, 1.1% Triton X-100, protease
inhibitors) and pre-cleared with 40 ml of pre-blocked ProtG beads
(1 mg/ml BSA, 4 h) (GE Healthcare) for 30 min with rotation.
The following amounts of antibodies were used for ChIP: anti-
dLint-1 #1( 8 ml/ChIP), anti-dCoREST (3 ml/ChIP), anti-H3
(1 ml/ChIP), anti-H3K4me2 (3 ml/ChIP), anti-H4K20me1 (Ab-
cam, 10 ml/ChIP), anti-H4K20me1 (Millipore, 0.25 ml/ChIP),
anti-H4K20me2 (10 ml/ChIP). As controls ChIPs were performed
ommiting antibody (beads control) or with pre-immune serum.
Incubation with antibodies was performed overnight, prior to
incubation for 2 h with 35 ml of 1:1 ProtG slurry at 4uC.
Precipitates were serially washed for 10 min, three times with low
salt wash buffer (20 mM Tris-HCl pH 8.0, 150 mM NaCl, 2 mM
EDTA, 0.1% SDS, 1% Triton-X-100), three times with high salt
wash buffer (20 mM Tris-HCl pH 8.0, 500 mM NaCl, 2 mM
EDTA, 0.1% SDS, 1% Triton-X-100), once with LiCl wash buffer
(10 mM Tris pH 8.0, 250 mM LiCl, 1 mM EDTA, 1% NP-40,
1% sodium deoxycholate), once with TE buffer. Immunoprecip-
itates were eluted twice with 250 ml elution buffer (1% SDS, 0.1 M
NaHCO3) for each 15 min at RT and crosslinks were reversed by
addition of 20 ml 5 M NaCl and heating at 65uC overnight.
Following addition of 10 ml of 0.5 M EDTA, 20 ml 1 M Tris-HCl,
pH 6.5 and 2 ml of 10 mg/ml Proteinase K samples were
incubated for 1 h at 45uC. DNA was purified with peqGOLD
Cycle-Pure Kit (Peqlab) and subjected to gene-specific qPCR.
Amplifications were performed in triplicates and mean values were
expressed as percentage of input compared with pre-immune
serum control. Standard deviation was calculated from the
triplicates, and error bars are indicated accordingly.
ChIP–Seq
ChIP–Seq was carried out on an Illumina Genome Analyzer IIx
according to the manufacturer’s instructions. Raw Illumina
sequence reads (36 bp) were approximately counted using a
bloom filter (collision probability 10‘28) and aligned to the
Drosophila melanogaster genome (Ensembl 63) with bowtie 0.12.7 [19]
allowing at most two mismatches (-n 2) with a mismatch quality
sum of 70 (-e 70) and restricting to exactly one mapped location (-
m 1 -k 1). Peak calling was performed with MACS [20] (1.4.0rc2
20110214 (Valentine), modified to read BAM files enhanced with
a count for each read). MACS allowed a maximum of 3 repetitions
of each (position, strand) tuple to exclude PCR artifacts, after a
poisson distribution based argument on the repetition probability.
The same de-deduplication was applied through out our analysis.
For comparison of different lanes, read counts were normalized to
1 million uniquely mapping reads. Peaks from different conditions
were considered overlapping when they shared at least 1 bp. Gene
annotation was obtained from Ensembl revision 63. Transcription
start sites were extracted from Ensembl transcript annotations to
include internal TSSs.
Microarray analysis
Expression analysis was performed using Affymetrix Gene 2.0
microarrays following standard protocols. RNAi to deplete
dL(3)mbt and dLint-1 was performed as described above in three
biological replicates. RNAi directed against EGFP was performed
as a control. Total RNA was extracted from RNAi-transfected
cells after 5 d using the peqGOLD total RNA kit (Peqlab).
Samples were prepared according to standard Affymetrix proto-
cols using the GeneChipFluidics Station 450 (protocol
FS450_0002) and hybridized to the Affymetrix GeneChip
Drosophila Genome 2.0 Array. Scans were carried out on an
Affymetrix GeneChip Scanner GSC3000_7G and the fluores-
cence intensities were analyzed with Affymetrix GCOS Software
1.4. Raw data were normalized with the gcrma package of
Bioconductor (http://www.bioconductor.org). Gene lists were
filtered with the following threshholds: fold change $1.5, adj.
p#0.05 (Benjamin Hochberg correction).
Primers
Primers used for RT–qPCR, ChIP–qPCR, and cloning
experiments are listed in Table S4.
Supporting Information
Figure S1 Purification and identification of dL(3)mbt and dLint-
1 interacting proteins. (A) Stable expression of FLAG-dL(3)mbt in
S2 cells. Nuclear extracts from control cells (mock, lanes 1 and 2)
and cells stably expressing FLAG-dL(3)mbt (lanes 3 and 4) were
immunoprecipitated with FLAG antibody (lanes 2 and 4) and
analyzed by Western blot as indicated. Lanes 1 and 3: 5% input.
(B) FLAG affinity purification of FLAG-dL(3)mbt stably expressed
in S2 cells (left panel, compare Figure 1B). Bands that were excised
and analyzed by peptide mass fingerprinting (right panel) are
denoted on the right with capital letters. (C) Stable expression of
dLint-1-FLAG in S2 cells. Nuclear extracts from control cells
(mock, lanes 1 and 2) and two S2 cell lines stably expressing dLint-
1-FLAG (line #1: lanes 3 and 4; line #2: lanes 5 and 6) were
precipitated with FLAG antibody. Immunoprecipitates were
analyzed by Western blot using antibodies as indicated (lanes 2,
4 and 6). Lanes 1, 3 and 5: 5% input. (D) FLAG affinity
purification of dLint-1-FLAG stably expressed in S2 (line #2) cells
(left panel, compare Figure 1E). Bands that were excised and
analyzed by peptide mass fingerprinting (right panel) are denoted
on the right with capital letters. Note that dCoREST and dLsd1
comigrate and were identified from the same band. (B) and (D)
Mass spectrometry data are expressed as probability based
molecular weight search (Mowse) scores, including the number
of peptides, which matched the identified protein (queries
matched). Scores, greater than 60, are significant (p,0.05).
Identified polypeptides are given with the according GI number
in NCBI, the protein name, if available and the CG gene number,
including the corresponding isoform.
(TIF)
Figure S2 Alignment of PHD-like motifs of dLint-1 Drosophila
homologues. Multiple sequence alignment of dLint-1 (CG1908)
Drosophila homologues, generated with ClustalW2 program.
Drosophila species are denoted on the left. The C4HC3 PHD-like
motif is written in bold and depicted below the alignment. Cys and
His residues are colour-coded in yellow and green. Basic residues
(Arg and Lys) are illustrated in red and acidic residues (Asp and
Glu) in blue. Positions of amino acid residues (referring to the full
length protein) of D. melanogaster and other D. species, are depicted
on top and on the right, respectively. Conservation of residues is
displayed below the multiple alignment as follows: ‘*’: Identical
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tions.
(TIF)
Figure S3 dLint1 interacting proteins coimmunoprecipitate
from embryo extracts. Nuclear extracts from 0 to 12 hr old
Drosophila embryos were precipitated with protein G beads (beads
control, lane 3) and beads loaded with dLint-1 #1 antibody (lane
2) and analyzed by Western blot as indicated (lanes 2 and 3). dMi-
2 served as a negative control. Lane 1: 5% input; lane 4 contains
dLint-1 antibody (antibody control).
(TIF)
Figure S4 Comparison of dLint1 ChIP-Seq peaks obtained from
two different cell lines. Peaks identified in either S2 or Kc ChIP-
Seq data were merged. For each resulting region (possibly
spawning multiple peaks) tag count normalized to one million
reads was log 2 transformed and plotted. Color indicates whether
a region was called by MACS in S2 (green), Kc (blue) or both
conditions (red).
(TIF)
Figure S5 dLint-1 peaks cluster around TSSs. (A) Approxi-
mately 58% of dLint-1 peaks identified in S2 cells overlap with a
known transcription start site (TSS). (B) Histogram depicting the
distribution of distances from dLint1 peak summits (i.e. region of
highest signal intensity) to the next TSS. Distances above 1000 bp
were truncated to 1000 bp.
(TIF)
Figure S6 LINT target promoters are devoid of H4K20 mono-
methylation. Chromatin from cells treated with RNAi against
dPR-Set7 or EGFP (control) was precipitated with H4K20me1 or
IgG antibodies as indicated. ChIP signals are shown for swa and
nos promoter regions, an intergenic region and the actin gene as
denoted below the panel.
(TIF)
Table S1 dL(3)mbt and dLint-1 bind to germline-specific MBTS
and SWH target genes. Genes were visually inspected for
dL(3)mbt peaks (Richter et al. 2011), dLint-1 peaks in Kc cells
and dLint-1 peaks in S2 cells. +: at least one peak.
(DOC)
Table S2 dL(3)mbt and dLint-1 regulate germline-specific
MBTS genes. Genes with a fold change $1.5 (adj. p#0.05) were
considered deregulated.
(DOC)
Table S3 Top 50 genes repressed by Lint-1.
(DOC)
Table S4 Primer sequences.
(DOC)
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